Home/Filings/4/0001104659-17-039525
4//SEC Filing

Mead Johnson Nutrition Co 4

Accession 0001104659-17-039525

CIK 0001452575operating

Filed

Jun 14, 8:00 PM ET

Accepted

Jun 15, 3:47 PM ET

Size

43.9 KB

Accession

0001104659-17-039525

Insider Transaction Report

Form 4
Period: 2017-06-15
Urbain Charles M
President, Asia and Europe
Transactions
  • Disposition to Issuer

    Restricted Stock Units

    2017-06-15$90.00/sh5,750$517,5000 total
    Common Stock (5,750 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2017-06-15$16.24/sh30,000$487,2000 total
    Exercise: $73.76Exp: 2026-02-28Common Stock (30,000 underlying)
  • Disposition to Issuer

    Performance Shares

    2017-06-15$90.00/sh10,740$966,6000 total
    Common Stock (10,740 underlying)
  • Disposition to Issuer

    Restricted Stock Units

    2017-06-1514,4930 total
    Common Stock (14,493 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2017-06-15$15.35/sh17,700$271,6950 total
    Exercise: $74.65Exp: 2023-02-27Common Stock (17,700 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2017-06-15$8.45/sh16,203$136,9150 total
    Exercise: $81.55Exp: 2024-02-28Common Stock (16,203 underlying)
  • Award

    Performance Shares

    2017-06-15+7,82810,740 total
    Common Stock (7,828 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2017-06-15$16.24/sh38,889$631,5570 total
    Exercise: $73.76Exp: 2026-02-28Common Stock (38,889 underlying)
  • Award

    Performance Shares

    2017-06-15+1,6542,885 total
    Common Stock (1,654 underlying)
  • Disposition to Issuer

    Common Stock

    2017-06-15$90.00/sh56,442$5,079,7800 total
  • Disposition to Issuer

    Restricted Stock Units

    2017-06-159,6620 total
    Common Stock (9,662 underlying)
  • Disposition to Issuer

    Restricted Stock Units

    2017-06-15$90.00/sh3,174$285,6600 total
    Common Stock (3,174 underlying)
  • Disposition to Issuer

    Restricted Stock Units

    2017-06-15$90.00/sh2,481$223,2900 total
    Common Stock (2,481 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2017-06-15$31.14/sh19,898$619,6240 total
    Exercise: $58.86Exp: 2021-03-02Common Stock (19,898 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2017-06-15$11.74/sh15,349$180,1970 total
    Exercise: $78.26Exp: 2022-03-02Common Stock (15,349 underlying)
  • Disposition to Issuer

    Performance Shares

    2017-06-15$90.00/sh2,885$259,6500 total
    Common Stock (2,885 underlying)
Footnotes (21)
  • [F1]Pursuant to the Agreement and Plan of Merger, dated February 10, 2017, by and among Mead Johnson Nutrition Company ("MJN"), Reckitt Benckiser Group plc ("RB"), and Marigold Merger Sub, Inc. (the "Merger Agreement"), at the effective time of the merger, each share of MJN common stock held by the reporting person was converted into the right to receive a cash payment equal to $90.00 per share.
  • [F10]Pursuant to the Merger Agreement, at the effective time of the merger, the stock options held by the reporting person were cancelled in exchange for a lump-sum cash payment equal to the product of (i) the number of shares of common stock for which such stock option has not been exercised and (ii) the difference, if any, between the merger consideration ($90.00) and the exercise price of the stock option.
  • [F11]One-third of this stock option was scheduled to vest on each of the first, second and third anniversaries of the March 2, 2011 grant date.
  • [F12]One-third of this stock option was scheduled to vest on each of the first, second and third anniversaries of the March 2, 2012 grant date.
  • [F13]One-third of this stock option was scheduled to vest on each of the first, second and third anniversaries of the February 27, 2013 grant date.
  • [F14]One-third of this stock option was scheduled to vest on each of the first, second and third anniversaries of the February 28, 2014 grant date.
  • [F15]One-third of this stock option was scheduled to vest on each of the first, second and third anniversaries of the February 29, 2016 grant date.
  • [F16]One-fourth of this stock option was scheduled to vest on each of the first, second, third and fourth anniversaries of the February 29, 2016 grant date.
  • [F17]Each performance share ("PSU") represents the contingent right to receive one share of common stock.
  • [F18]Represents the target number of PSUs for any one year performance period not yet completed as of the effective time of the Merger to which the reporting person became entitled on an accelerated basis pursuant to the Merger Agreement at the effective time of the Merger.
  • [F19]Pursuant to the Merger Agreement, at the effective time of the merger, the PSUs held by the reporting person were cancelled in exchange for a lump-sum cash payment equal to the product of (i) the PSU Amount and (ii) $90.00 per share. The PSU Amount represents the total number of shares of Mead Johnson common stock that would have been delivered to the reporting person based on (1) actual performance goal achievement for any completed one year performance periods and (2) target performance goal achievement for any one year performance period not yet completed.
  • [F2]Each restricted stock unit ("RSU") represents the contingent right to receive one share of common stock.
  • [F20]These PSUs were originally scheduled to convert into shares of common stock upon vesting and settlement in the first quarter of 2018.
  • [F21]These PSUs were originally scheduled to convert into shares of common stock upon vesting and settlement in the first quarter of 2019.
  • [F3]Pursuant to the Merger Agreement, at the effective time of the merger, the RSUs held by the reporting person vested and were cancelled in exchange for a lump-sum cash payment equal to the product of (i) the number of shares of common stock subject to such RSU immediately prior to the effective time of the merger and (ii) $90.00 per share.
  • [F4]This RSU was originally scheduled to vest on February 28, 2018.
  • [F5]This RSU was originally scheduled to vest on February 26, 2019.
  • [F6]This RSU was originally scheduled to vest on February 29, 2020.
  • [F7]One-third of this RSU was scheduled to vest on each of the first, second and third anniversaries of the February 28, 2017 grant date. Pursuant to the Merger Agreement, at the effective time of the merger, the RSUs held by the reporting person converted into phantom RSUs representing a number of shares of RB common stock ("RB RSUs"). With this conversion, the reporting person received a number of RB RSUs equal to: (a) the original number of RSUs granted to the reporting person multiplied by $90.00 per share; divided by (b) the RB share closing price on the London Stock Exchange on the closing date of the merger. The RB RSUs will continue to be subject to time-based vesting over the applicable vesting period and, upon vesting, will settle in cash based on the RB share closing price on the London Stock Exchange on the applicable vesting date.
  • [F8]In the event that the reporting person's employment is terminated without "Cause" or for "Good Reason" during the vesting period, the RB RSUs will vest in full as of the date of such termination.
  • [F9]This RSU was originally scheduled to vest on February 28, 2020. Pursuant to the Merger Agreement, at the effective time of the merger, the RSUs held by the reporting person converted into phantom RSUs representing a number of shares of RB common stock ("RB RSUs"). With this conversion, the reporting person received a number of RB RSUs equal to: (a) the original number of RSUs granted to the reporting person multiplied by $90.00 per share; divided by (b) the RB share closing price on the London Stock Exchange on the closing date of the merger. The RB RSUs will continue to be subject to time-based vesting over the applicable vesting period and, upon vesting, will settle in cash based on the RB share closing price on the London Stock Exchange on the applicable vesting date. In the event that the reporting person's employment is terminated without "Cause" or for "Good Reason" during the vesting period, the RB RSUs will vest in full as of the date of such termination.

Documents

1 file

Issuer

Mead Johnson Nutrition Co

CIK 0001452575

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001452575

Filing Metadata

Form type
4
Filed
Jun 14, 8:00 PM ET
Accepted
Jun 15, 3:47 PM ET
Size
43.9 KB